Krempa David
Reporting owner on Forms 3, 4 and 5, CIK 1968254.
Krempa David reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-10-06.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| ETON · Eton Pharmaceuticals, Inc.CIK 1710340 | officer (Chief Business Officer) | 1 | 2026-10-06 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| ETON · Eton Pharmaceuticals, Inc.Common Stock | 2026-10-06 | S sold | -4,166 | $55.0663 | 43,381 | Form 4 |
| ETON · Eton Pharmaceuticals, Inc.Common Stock | 2026-10-02 | M exercised | +10,522 | 47,547 | Form 4 | |
| ETON · Eton Pharmaceuticals, Inc.Restricted Stock Units, derivative | 2026-10-02 | M exercised | -10,522 | $0 | 21,044 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001437749-26-032240 | Eton Pharmaceuticals, Inc. | 2026-10-06 |